With PharmSci360 just around the corner, we're excited about all of the talks and posters with Global Health topics. To help our community to easily find these presentations, we've put together a few guides. Attached and copied below is a guide for topics related to Antivirals.
If you want to highlight a specific PharmSci360 presentation of interest (or if we've missed one that should be on this list), please respond!
Don't forget to attend the Global Health Community meeting taking place from 4-5pm on Monday, Oct 21 at Spotlight Stage C.
------------
Monday
|
Time
|
Location
|
Poster / Presentation
|
Speaker
|
Title
|
|
9:00
|
155F
|
Presentation
|
Alex Langford, Pfizer
|
Accelerating Development of Vaccines for Low- and Middle-Income Countries
|
|
11:30
|
07-40
|
Poster
|
|
Bilayer Microneedle Array Patch for Transdermal Delivery of Novel Capsid Inhibitor Lenacapavir to Mitigate the Risk of Pediatric HIV Infection
|
|
11:30
|
03-17
|
Poster
|
|
Enhancing Gonorrhea Vaccine Efficacy: Dosage Response Analysis of a Novel Microparticulate Formulation
|
|
12:30
|
09-52
|
Poster
|
|
An Exploratory Study of DHA-Incorporated Nanoformulations for Delivery of Antiretrovirals to Lymphatic HIV-Reservoirs
|
|
13:30
|
251 DE
|
Presentation
|
Brian Corrigan, Pfizer
|
Keynote: From Theory to Therapy: Charting the Course from the Lab to Global Health Outcomes in Translational Science
|
|
13:30
|
01-06
|
Poster
|
|
Formulation of a Poorly Soluble Antiviral Drug as Microparticle Powder for Nasal Breath Intake Against Respiratory Infections
|
|
13:30
|
05-29
|
Poster
|
|
Self-Nanoemulsifying Systems Containing Ionic Liquids of Rilpivirine for Improved Oral Bioavailability and Penetration in the HIV Sanctuary Sites
|
|
14:30
|
09-52
|
Poster
|
|
Development of Dry Powder Formulation of PAV-104 for Pulmonary Drug Delivery
|
|
14:30
|
04-22
|
Poster
|
|
Discovery and Development of a New Therapeutic Product for the Treatment Long Covid
|
|
14:30
|
03-17
|
Poster
|
|
Targeted Antiretroviral Therapy Using Controlled Release Polymeric Nanoparticles for Brain Viral Load Reduction and Management of HIV Associated Neurocognitive Disorder (HAND)
|
|
15:30
|
04-22
|
Poster
|
|
Anti-Viral and Anti-Inflammatory Effects of Novel PPARγ Agonist, INT131, in an EcoHIV Mouse Model: Relevance to the Treatment of HIV-Associated Neurocognitive Disorders
|
|
16:00
|
Spotlight Stage C
|
Meeting
|
|
Global Health Community Meeting
|
Tuesday
|
Time
|
Location
|
Poster / Presentation
|
Speaker
|
Title
|
|
7:00
|
Salt Lak AB
|
Event
|
|
Mentor Breakfast
|
|
9:30
|
05-26
|
Poster
|
|
On-Demand Multi-Indication Fast-Disintegrating Tablets for HIV Prevention and Birth Control: Formulation Development and In Vitro Evaluation
|
|
10:30
|
05-26
|
Poster
|
|
3D-Printed Short Nanofibers/Hydrogel-Based Vaginal Films as a Novel System for the Delivery of Anti-HIV Microbicide Drugs
|
|
10:30
|
251 F
|
Presentation
|
Reina Bendayan, University of Toronto
|
Novel Molecular Targets for the Treatment of HIV-Associated Neurocognitive Disorders
|
|
12:30
|
05-30
|
Poster
|
|
Controlled Release Mannose and RVG-9R Functionalized PLGA Nanoparticles for Targeting the Brain Viral Reservoir for the Management of HIV Associated Neurocognitive Disorder
|
|
12:30
|
05*25
|
Poster
|
|
How are Medicines Administered to Pre-school Children? Current Status of a Global Survey on the Use of Dosing Vehicles
|
|
14:30
|
01-02
|
Poster
|
|
Development of an Extended Action Fostemsavir (FTR) Lipid Nanoparticle (LNP) Antiretroviral Therapy
|
Wednesday
|
Time
|
Location
|
Poster / Presentation
|
Speaker
|
Title
|
|
9:00
|
251ABC
|
Presentation
|
Rohit Rao, Pfizer
|
Model-Informed Vaccine Development Opportunities
|
|
9:00
|
251DE
|
Presentation
|
Wendy Picking, University of Missouri-Columbia
|
A Dual Prophylactic/therapeutic Vaccine Against Pseudomonas Aeruginosa, Wendy Picking
|
|
9:30
|
251ABC
|
Presentation
|
Jeffrey Sachs, Merck
|
Pharmacometrics Symbiotically Infects Vaccinology: MIDD for Increasing PoS and Reducing Resource Use
|
|
9:30
|
251DE
|
Presentation
|
Li Li, Pfizer
|
Patient Focused Vaccine Drug Product Development: Formulation, Process and Manufacturing Approaches
|
|
9:30
|
155B
|
Presentation
|
Pavan Muttil, University of New Mexico
|
Inhaled Vaccines: Advancing Respiratory Infection Prevention and Overcoming Current Limitation
|
|
10:00
|
251ABC
|
Presentation
|
Will Lykins, AAHI
|
Case Studies of Rational Design and Translation for Next-Generation Vaccine Adjuvants
|
|
10:30
|
09-48
|
Poster
|
|
Comparison of Plant and Animal Sources of Squalene as Adjuvants for Use in Vaccine Applications
|
------------------------------
Erica Schlesinger Ph.D.
VP, Technical Development
Seran Biosciences, LLC
Bend OR
[email protected]Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------